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Summary 
The Nur77/Nurrl  family of DNA binding proteins has been reported to be required for the 
signal  transduction of CD3/T cell receptor (TCR)-mediated apoptosis in T  cell hybridomas. 
To determine the role of this family of DNA-binding proteins in thymic clonal deletion, trans- 
genic (Tg) mice bearing a dominant negative mutation were produced. The transgene con- 
sisted  of a truncated Nur77  (ANur77) gene encoding the DNA-binding domain of Nur77 li- 
gated  to  a  TCR-[3  enhancer  resulting  in  early  expression  in  thymocytes.  Apoptosis  of 
CD4+CD8 +  thymocytes  mediated  by  CD3/TCR  signaling  was  greatly  inhibited  in  the 
ANur77 Tg mice, compared with non-Tg littermates, after treatment with anti-CD3 or anti- 
TCR antibody in vivo and in vitro. Clonal deletion of self-reactive T  cells was investigated in 
ANur77-Db/HY TCR-ot/~3 double Tg mice. There was a five-fold increase in the total num- 
ber of thymocytes expressing self-reactive Db/HY TCR-et/~3 in the ANur77-TCR-ot/[3 dou- 
ble Tg male mice. Deficient clonal deletion of self-reactive thymocytes was demonstrated by a 
10-fold increase in the CD4+CD8 + thymocytes that expressed Tg TCR-a/[~.  There was  an 
eight-fold increase in CD8 +, DB/Hy TCR-ot/[3 T  cells in the lymph nodes (LN) of ANur77- 
Db/Hy TCR-o_/[3 double Tg compared with Db/Hy TCR-0~/I3 Tg male mice. In spite of de- 
fective clonal deletion, the T  cells expressing the Tg TCR were functionally anergic. In vivo 
analysis revealed increased activation and apoptosis of T  cells associated with increased expres- 
sion of Fas and Fas ligand in LN of ANur77-Db/Hy TCR-oJI3 double Tg male mice. These 
results indicate that inhibition of Nur77/Nurrl  DNA binding in T  cells leads  to inefficient 
thymic clonal deletion, but T  cell tolerance is maintained by Fas-dependent clonal deletion in 
LN and spleen. 
C 
lonal  deletion  and  clonal  anergy  are  the  primary 
mechanisms for induction of se•tolerance  in T  cells 
(1).  During  thymic  maturation,  thymocytes bearing self- 
reactive TCR undergo clonal deletion and are eliminated 
by programmed cell death or apoptosis (2, 3). Thymocytes 
with  intermediate  to high  density levels of expression of 
the  TCR  undergo negative  selection at the  CD4+CD8 + 
(double positive  [DP] I)  stage  of thymocyte development 
1Abbreviations used in  this paper: AICD, activation induced cell death; 
BrdU, bromodeoxyuridine; ANur77, dominant negative mutation of 
Nur77; DP, double positive; FasFP, Fc-Fas fusion protein; M33, Db/HY 
TCR anticlonotypic mAb; NBRE, NGFI-B response element; NGF, 
nerve growth factor;  Tg, transgenic;  Tg71, TCR transgenic mice express- 
ing the Db/Hy TCR; TINUR, transcriptionally  inducible nuclear  recep- 
tor; TUNEL, terminal digoxigenin  nucleotide  endlabeling. 
(4-8). Downmodulation of the TCR,  CD4,  and/or CD8 
molecules on the surface of T  cells has been proposed as a 
mechanism  for  escape  from  negative  selection  (8-12). 
Thus, the TCR generates signals that are capable of medi- 
ating negative selection of thymocytes by clonal deletion. 
However, the signaling mechanisms required for negative 
selection of thymocytes remain unknown. 
Several molecules and pathways known to be of impor- 
tance  in  apoptosis  have  been  described  in  the  thymus; 
however,  their contribution to  clonal deletion and toler- 
ance induction remains controversial (1). Although knock- 
out  of p53  leads  to  decreased sensitivity of murine  thy- 
mocytes to radiation-induced apoptosis, negative selection 
remains  intact  (13-15).  Fas is  a  cell surface receptor that 
mediates apoptosis by interaction with a specific ligand and 
is  expressed  on  most  murine  thymocytes  (16--19).  Al- 
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mune  disease  in lpr/lpr and gld/gld mice,  respectively  (18- 
20), no major negative selection defects have been found in 
lpr/lpr mice (21-25).  Therefore, it is unlikely that Fas anti- 
gen is directly involved in negative selection in the thymus. 
Bcl-2 prevents thymocyte apoptosis that is induced by ra- 
diation,  steroids,  and  other  chemicals  (26-28).  Expression 
of bcl-2 has been reported to be decreased in CD4+8 + thy- 
mocytes, but not in mature thymocytes, and has been pro- 
posed to play a role  in inhibition  of negative  selection  in 
the thymus (29). However, bcl-2 knockout mice do not ex- 
hibit excessive clonal deletion in the thymus (30)  and, con- 
versely,  bcl-2 transgenic  (Tg)  mice do not exhibit  a major 
defect in negative selection or T  cell tolerance (28, 31-33). 
Double Tg bcl-2+Db/HY  TCR  mice show that constitu- 
tive expression of bcl-2 increases the survival of thymocytes 
in  the  absence  of positive  selection  (34-36).  The  bcl-2 
transgene  also reduces the  efficiency of negative selection, 
but  the mature peripheral  T  cells  that appear in increased 
numbers are not autoreactive. Thus, although bcl-2 can play 
a role in both positive  and negative  selection,  tolerance is 
maintained by a mechanism that can bypass bcl-2. 
Nerve growth factor (NGF)I-B/Nur77  is a growth fac- 
tor-inducible member of the steroid/thyroid hormone re- 
ceptor  superfamily  originally  identified  in  NGF-treated 
P12 pheochromocytoma cells  (37) and in serum-stimulated 
fibroblasts  (38).  NGFI-B/Nur77  is  transcriptionally  regu- 
lated as an immediate-early gene and is rapidly activated by 
phosphorylation after stimulation with serum or NGF  (39, 
40). NGFI-B/Nur77 has a centrally located, highly conserved 
DNA-binding  domain  containing  two  zinc  fingers  and  a 
transcriptional  trans-activating  domain  (41-47).  NGFI-B/ 
Nur77  gene is expressed in thymic medulla  and is rapidly 
upregulated  in  T  cell  hybridomas  and  thymocytes  after 
treatment with anti-CD3 or anti-TCR,  and this expression 
has  been  correlated  with  induction  of apoptosis  (48,  49). 
Blocking  of NGFI-B  with  either  a  dominant  negative 
truncated  (48)  or antisense  (49) NGFI-B/Nur77 gene pre- 
vented TCR/CD3  signaling-mediated  apoptosis in T  cell 
hybridomas.  There  are  at least  two  gene  families  with  an 
identical NGFI-B response element  (NBRE) AAAGGTCA 
(50). The first member of this family, referred to as Nur77 
(mouse), NGFI-B (rat), and NAK-1  (human) peaks 1 h  af- 
ter stimulation of the PEER T  cell line. The second mem- 
ber,  referred  to  as  Nurrl  (mouse),  regenerating  liver  nu- 
clear  receptor-1  (rat),  and  transcriptionally  inducible 
nuclear receptor (TINUR  [human]) peaks 24 h  after stim- 
ulation and correlates with apoptosis. Although Nur77 has 
been shown to be important in T  cell signaling and apopto- 
sis  (48,  49),  other signaling proteins  can also contribute  to 
T  cell maturation and apoptosis, This was recently demon- 
strated in a Nur77 mutant mouse, in which T  cells  did not 
exhibit defective apoptosis after anti-CD3 cross-linking and 
exhibited normal T  cell development and apoptosis in Db/ 
HY TCR  Tg mice (51). The present experiments utilize  a 
truncated Nur77 transgene capable of expressing high lev- 
els  of a  nonfunctional DNA-binding protein  to block the 
NBRE  in T  cells.  The  results  indicate  that  the  truncated 
form  of  the  dominant  negative  mutation  of  Nur77 
(ANur77)  gene  binds  to  the  NBRE,  inhibits  TCR/CD3 
signaling-mediated apoptosis, and also interferes with selec- 
tion and clonal deletion in the thymus of ANur77-Db/Hy 
TCR  double Tg mice. 
Materials  and Methods 
Production of  Tg  Mice Expressing the  Truncated Nur77  Gene. 
The mouse Nur77  1,200-bp  cDNA fragment corresponding to 
nucleotides  (nt) 794-1993  and  encoding  the  truncated  mouse 
Nur77 at residues from 229 for Met to 601 for Phe was amplified 
by reverse  transcription,  using normal mouse thymus RNA as a 
template.  The primers used for PCR were 5'-CCACCATGC- 
CAGCAGCTTTC-3'  and  5'-GGATCCGTGGGCTATAG- 
GCT-3' (complementary to nt 1977-1993).  The italicized nucle- 
otides  are  not derived from the mouse Nur77  cDNA sequence 
but are added to a eukaryotic translation  consensus sequence (un- 
derlined)  in front of a AUG for Met or constitute the sequence 
(underlined)  for the BamHI restriction  site. The amplified  Nur77 
cDNA fragment was directly subcloned into PCR TA vector (In- 
vitrogen,  San  Diego,  CA).  The  insert  Nur77  cDNA was  con- 
firmed by a standard  DNA sequencing technique. The truncated 
Nut77  capable  of binding to the homologous Nur77 DNA re- 
sponse  element  was  excised  with  BamHI  and  cloned  into 
p913C~31E vector (52, 53). The TCR f3 chain enhancer has been 
demonstrated to result in T  cell-specific  expression.  The expres- 
sion constructed was excised and used to produce Tg mice as pre- 
viously described  (53). TCR-cr  TCR Tg mice reactive with 
Db/HY  antigen  (Tg71)  were  obtained  as  previously described 
(54) and backcrossed with the ANur77 Tg mice. 
Southern Blot Analysis of the ANur77 Transgene.  Tail  DNA was 
prepared and digested with the indicated restriction  enzymes.  Ap- 
proximately 10 &g of the digested DNA was separated  on a 0.7% 
agarose gel, blotted to a nylon membrane, and hybridized with a 
32p-labeled full-length Nur77 cDNA probe. 
Nudear Extract Preparation.  Nuclear extract  was prepared from 
single cell suspensions of thymocytes of ANur77 Tg mice and of 
mice having no transgene,  respectively,  as described  (55).  Thy- 
mocytes were  cultured in media or stimulated  with  100  ng/ml 
PMA  and  500  p~g/rnl  ionomycin  (Calbiochem-Novabiochem 
Corp., San Diego, CA) for 6 h.  The protein concentration was 
determined  by  bicinchoninic  acid  protein  assay reagent  kit 
(Pierce,  Rockford, IL), and aliquots  were frozen at  -80~  until 
an electrophoretic mobility shift assay was performed. 
Electrophoretic Mobility Shift Assay.  Oligonucleotides  contain- 
ing the NBRE were synthesized  at the University of Alabama at 
Birnfingham  (Oligonucleotide  Core Facility). They are sense strand 
5'-GGAGTTTTAAAAGGTCATGCTCAATTT-3'  and  anti- 
sense  strand  5'-GGAAATTGAGCATGACCTTTTAAAACT-3' 
(44). The sense and antisense  strands were mixed in equal  molar 
amounts,  annealed by heating  to  100~  for 2  rain  and slowly 
cooled at 37~  for 4 h; 20 ng of the double stranded  oligonucle- 
otides  were endlabeled  with c~-[32p]dCTP by the Klenow frag- 
ment reaction.  The unincorporated ct-[32p]dCTP  was removed 
by passing  the  reaction  through  a  sodium-tris-EDTA select-D 
G25 column (5 prime-~3 prime, Inc., Boulder, CO). A 0.1-ng 
('-~20,000 cpm) radioactive  probe was added to 20 p~g of extract 
protein solution, which had been mixed with 2 ~g of poly(dI- 
dC) and reaction buffer (10 mM Tris, pH 7.5, 1 mM dithiothrei- 
tol, 100 mM KC1, 1 mM EDTA, 0.2 mM PMSF, 1 mg/ml BSA, 
and 5% glycerol) at 25~  for 10 rain (56). In the competition as- 
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radiolabeled probe before they were placed into the reaction mix- 
ture. After incubation at 25~  for 20 rain, the samples were frac- 
tionated on a nondenaturing  polyacrylamide gel in 0.25  tris bo- 
rate EDTA, 5% glycerol. After electrophoresis, the gel was dried by 
vacuum and autoradiography was carried out at -70~  overnight. 
Northern Blot Analysis.  Total RNA was isolated from the thy- 
mus, transferred onto nylon nitrocellulose membranes, and probed 
with a 1.2-kb Nur77 cDNA fragment or 13-actin as control. 
Antibodies.  Anti-CD3  (clone  145.2Cll),  anti-CD4  (clone 
GK  1.5),  anti-CD8  (clone 53-47),  anti-TCR  (clone H57),  and 
anti-Fas  (clone Jo2)  were purchased  from PharMingen  (San Di- 
ego, CA). The Db/HY TCR anticlonotypic mAb M33 was pro- 
duced as previously described (24). 
Induction of Apoptosis In  Vivo and In  Vitro.  Thymocyte  apop- 
tosis  was  induced  in  vivo by  daily injection of 50  ~g i.p.  anti- 
CD3 or anti-TCR, antibody for 3  d  and was analyzed  12 h  after 
the last dose, or it was induced by a single injection of 10 txg i.p. 
dexamethasone and analyzed 12 h later. For in vitro induction of 
apoptosis,  the thymocytes were incubated for different time peri- 
ods  on  6-well flat  bottom  plates  (Coming,  Coming,  NY)  that 
had been coated with either  10  Ixg/ml anti-CD3  or cultured in 
the presence of 10 IxM dexamethasone (Sigma Chemical Co., St. 
Louis, MO). 
Expression of CD3~.  Single  cell  suspensions  of  thymocytes 
were cultured in 6-well flat bottom plates with either anti-CD3 
or control antibody for 5 rain followed by protein extract prepa- 
ration.  Cells  (106) were  lysed in lysis  buffer  (20  mM  Tris-HC1, 
pH 7.5,  0.5% Triton )(-100,  1 mM PMSF,  1 i~g/ml leupeptin, 
and  1  p,g/ml aprotinin)  and  equivalent amounts  of total cellular 
protein  lystates  (20  Ixg) were  separated  on  10%  SDS-polyacryl- 
amide gels, blotted to nitrocellulose membranes  (Bio-Rad Labo- 
ratories,  Hercules, CA), and incubated with antiphosphotyrosine 
antibody.  The  blots  were  counterstained  with  goat  anti-mouse 
IgG conjugated with alkaline phosphatase,  and incubated with nitro 
blue tetrazolium (17 mg/ml) and 5-bromo-4-chloro-3-indolylphos- 
phate  (33  mg/ml)  substrate  in 0.1  M  Tris-HC1  (pH  9.5)  (Sigma 
Chem. Co.). 
T Cell-mediated Cytotoxicity.  Peripheral  CD8 +  T  cells  were 
purified from  LN cells using a  murine  CD8  T  cell enrichment 
column  (R&D  Systems,  Inc.,  Minneapolis,  MN).  The  purified 
CD8 +  T  cells  were  stimulated  with  irradiated  spleen  cells  ob- 
tained from C57BL/6 male mice in the presence of 50 U/ml of 
IL-2 for 3  d.  Viable cells were  collected by centrifugation  over 
Ficoll. Con A-stimulated spleen cells from C57BL/6 male or fe- 
male  mice  were  labeled  with  51Cr  and  mixed  with  stimulated 
CD8 + T  cells at the indicated ratio. After incubation for 8 h, the 
51Cr  released  in  the  supematants  was  measured  using  a  gamma 
counter  (Packard  Industries,  Meriden,  CT)  and  the  specific re- 
lease calculated using the standard method. 
Assay for Fas Ligand Activity.  Unstimulated  LN  T  cells  were 
incubated with S  lCr-labeled Fas + C57BL/6- + / +  A20 target cells 
at different effector/target ratios in the presence and absence of 10 
Ixg/ml  of a  Fc-Fas  fusion protein  (FasFP,  57).  Release  of 51Cr 
into the supematant was assessed  8 h later using a gamma counter. 
The specific release was calculated using standard methods. 
Proliferative Response of Db  /HY-reactive T Cells.  Peripheral  CD8 + 
T  cells, purified as described above, were cultured in the presence 
of 50 U/ml of murine  IL-2  (Genzyme Corp.,  Cambridge,  MA) 
for the indicated time with irradiated (3,300 rad) syngeneic spleen 
cells obtained from C57BL/6 male or female mice. For measure- 
ment of proliferation,  1 IxCi of [3H]thymidine was added at  16 h 
before harvest. 
Flow Cytometry Analysis.  Single  cell  suspensions  of  thymo- 
cytes  or LN  cells  were  labeled  with  optimal  concentrations  of 
FITC-conjugated  anti-CD8,  PE-conjugated  anti-CD4,  or  PE- 
conjugated  anti-Fas  (PharMingen)  and  biotin-conjugated  M33 
(24)  followed by Tandem-Strepavidin.  Viable cells (10,000/sam- 
ple)  were  analyzed by flow cytometry on a  FACScan  |  (Becton 
Dickinson &  Co., Mountain View, CA) equipped with logarith- 
mic  scales  and  the  data  processed  in  a  Hewlett-Packard  (Palo 
Alto, CA) computer. The number of cells in each population was 
Figure 1.  Characterization  of ANur77  Tg mice.  (/t)  Detection of the 
wansgene by Southern  blot analysis. Southern  blot analysis of tail DNA 
carried out after digestion with BamHI revealed six hnes of ANur77 Tg 
mice.  BamHI digestion  hberated  a  1.3-kb  cDNA corresponding  to the 
Nur77 DNA-binding domain and also higher molecular weight endoge- 
nous genomic Nut77 DNA fragments at ~8 and 6 kb. Different  lines of 
Tg founder mice are designated according  to sex (M, male; F, female) as 
4-3M,  4-4M,  4-5M,  5-2F,  5-5F,  and  5-6F.  Experiments  were carried 
with the line drive from 4-4M. (B) Expression of the truncated  ANur77 
RNA transcript  in ANur77 Tg mice.  R.NA was prepared  from thymus 
(Thy), spleen (Spl), peripheral  LN (PLN), heart, and brain ofANur77 Tg 
mouse  (line 4-4M)  or non-Tg control mice. Non-Tg control mice ex- 
pressed a full-length  Nur77 transcript with a mol wt of",~3.7  kb in the 
lymphoid organs as well as nonlymphoid organs. ANur77 Tg mice ex- 
pressed the 3.7-kb  endogenous  Nur77  transcript  as well as an ~5.5-kb 
ANur77  transcript  in  tissue containing  T  cells. (C)  Gel shift  assay of 
Nur77 protein.  The NBRE was endlabeled and incubated  with the nu- 
clear  extract  derived  from  unstimulated  and  stimulated  thymocytes  of 
non-Tg or ANur77 Tg mice. Non-Tg and ANur77 Tg mice exhibited an 
identical size higher gel shift band  (A). ANur77  Tg mice also exhibited  a 
unique lower gel shift band (B). 
1881  Zhou et al. Figure 2.  Decreased deletion of CD4 +  8  + thymocytes after anti-CD3 or anti-TCIk treatment in ANur77 Tg mice. Non-Tg or ANur77 Tg mice were 
injected with 50 mg i.p. of either control or anti-CD3 or anti-TCR antibody daily for 3 d and analyzed on day 4. Non-Tg or ANur77 Tg mice were in- 
jected with dexamethasone (10 IxM i.p.) and analyzed 12 h later. (/1) Flow cytometric analysis  ofthymocyte subpopulation. Thymocyte suspensions were 
labeled with anti-CD4 or anti-CD8 and analyzed by flow cytometry analysis.  Percent thymocytes in each of the CD4 and CD8 subpopulations as defined 
by the cursors are shown on the graph. These data represent a typical flow cytometry analysis that was carried out using at least five different mice. (/3) 
TUNEL staining of the thymocytes from anti-CD3-treated non-Tg and ANur77 Tg mouse. The thymocytes were prepared as above. 10  s thymocytes 
were cytospun onto the slide and stained for apoptosis by the TUNEL technique.  (C) Tyrosine phosphorylation of the CD3~ chain after anti-CD3 cross- 
linking. Single cell suspensions of thymocytes were incubated with 10 ug/ml of either control antibody or anti-CD3 antibody for 5 min, followed by 
Western blot analysis  of CD3~ using an antiphosphotyrosine antibody. 
determined by quadrant analysis of contour graphs. 10,000 viable 
cells were analyzed by FACScan  | 
Apoptosis Analysis by Terminal Digoxigenin Nudeotide Endlabeling 
staining.  The  in situ nick translation method of DNA staining 
was used for in situ determination of apoptotic cells according to 
the published method, with slight modifications (58).  Briefly, 10  s 
cells were cytospun onto poly-L-lysine pretreated slides,  fixed in 
10% formalin for over 30 min, and the cells subjected to protein- 
ase K  digestion (10 p~g/ml at room temperature for 20 min). Af- 
ter extensive washing with ddH20, a reaction max containing 0.5 
gtm/ml  TdT,  10  btM  digitonigen  modified-dUTP,  and  TdT 
buffer was applied to the slide. The slides were incubated at 37~ 
for 1 h.  The poly-dUTP tail, which was synthesized at the bro- 
ken ends of DNA, was detected by alkaline phosphatase-conju- 
gated antidigitonigen antibody and NBT/BCIP substrate. At least 
200 cells were counted using light microscopy. 
Bromodeoxyuridine Incorporation In  Vivo and  In  Situ  Staining. 
Bromodeoxyuridine (BrdU) was purchased from Sigma Chemical 
Co. and was diluted to 5 mg/rnl in PBS (59).  Mice received i.p. 
injections with 1 mg BrdU/mouse at 6-h intervals for four doses 
and were  killed  1 h  after the last injection when LN were  re- 
moved and frozen in OCT. After frozen section, the slides were 
fixed in ice-cold ethanol (70%)  for 20 min, and the DNA dena- 
tured by incubation at room temperature for 20 rain in 3 N  HC1 
with  0.5%  Tween  20  (Sigma  Chemical  Co.).  The  slides  were 
then incubated 3-5 rain with 0.5 ml 0.1 M  sodium borate buffer, 
pH 8.5, followed by two further washes in PBS. The slides were 
then  incubated  at  room  temperature  for  30  min  with  FITC- 
conjugated anti-BrdU mAb (Boehringer Mannheim, Indianapo- 
lis, IN), washed in PBS, and mounted. Slides were examined and 
photographed using an Argon ion laser scanning confocal micro- 
scope (model 1000; Molecular Dynamics, Sunnyvale, CA). 
Results 
Production ofANur77  Tg Mice.  Six  lines  of mice  carry- 
ing ANur77 Tg DNA  were produced (Fig. 1 A). Digestion 
of tail DNA  with BamHI revealed the  expected  truncated 
Nur77  fragment  of  1.3  kb,  which  contained  the  DNA- 
binding  domain  without  the  transactivation  domain,  as 
well  as  the  genomic  Nur77  bands  of  higher  molecular 
weight.  The  transgene copy number varied from  approxi- 
mately 3  in the line designated 5-2F  to  10  in the  Tg line 
designated  4-3M  (Fig.  1  A).  Expression  of the  truncated 
ANur77  gene  in  the  Tg  mice  was  analyzed by Northern 
1882  Nur77/Nurr1 Response Element Signals T  Cell Apoptosis Table 1.  Comparison  of Thymocyte Deletion after Anti-CD3 Treatment in ANur77 Tg and non-Tg Control Mice 
Non-Tg  ANurr77  Tg 
Treatment  Total  DN  DP  CD4 +  CD8 +  Total  DN  DP  CD4 +  CD8 + 
ControlAb  114-  10  5.2 +2.2  84-+ 12  12--+2.3  8.4 +  1.5  128 +  12  13  +2.4  82 +  14  21  +4  14-+3 
Anti-CD3  16 +21.8  3.5 +  1.5  0.8 4- 0.3  8.0 +  1.5  4.8 +2.1  68 -4-8  8.1-+ 1.5  30-+5  19-+6  11_+ 2.5 
Percent deletion  86  33  99  33  43  50  38  63  10  24 
blot analysis  (Fig.  1 B).  Non-Tg control mice expressed a 
Nut77 mRNA transcript of~3.7 kb in both lymphoid and 
nonlymphoid organs. ANur77 Tg mice expressed an addi- 
tional transcript of 5.5  kb, corresponding to the truncated 
Nur77 gene, and a minigene including the CTt3 enhancer. 
The transgene  transcript was expressed highly in the  thy- 
mus, spleen, and LN, but was not expressed in the heart or 
brain.  This result indicated that the expression of ANur77 
controlled by the CT[3 enhancer was confined to the lym- 
phoid organs. To determine the ability of ANur77 protein 
to bind the  corresponding DNA-binding motif and com- 
pete with endogenous Nur77 protein, gel shift assays were 
performed with a double-strained oligonucleotide contain- 
ing  the  Nur77-binding  motif,  NBRE.  Nuclear  extracts 
were  prepared  from  the  thymocytes  of  non-Tg  and 
ANur77 Tg mice with and without stimulation with PMA 
plus ionomycin. In the unstimulated thymocytes from non- 
Tg mice, there was only minimal expression of the endog- 
enous  Nur77  DNA-binding protein indicated by a single 
high molecular weight gel shift band  (Fig.  1  C).  The ex- 
pression  of endogenous  Nut77  protein  was  greatly  in- 
creased at 6 h after stimulation. In unstimulated thymocytes 
of ANur77  Tg  mice,  there  was  high  expression  of the 
ANur77  protein,  as  demonstrated  by  a  lower  molecular 
weight gel shift band. After PMA plus ionomycin stimula- 
tion,  there  was increased  expression  of both the  endoge- 
nous  Nur77  gel  shift band  (band a)  and  the  ANur77  gel 
shift band (band 13). Both of these gel shift bands were the 
result of specific interaction  with  the  NBRE  because the 
binding could be competitively inhibited by addition of in- 
creasing concentrations  of unlabeled DNA containing the 
NBRE but not by an irrelevant DNA oligonucleotide (data 
not shown). These results indicate that IkNA encoding the 
truncated ANur77-binding protein is specifically expressed 
in  the  T  cells  of the  Tg  mice,  and  that  the  truncated 
ANur77  protein produced in  ANur77  Tg mice competi- 
tively inhibits  the  binding  of endogenous  Nur77  to  the 
NBRE. 
Inhibition of Anti- TCR/ CD3-mediated  Thymocyte Apopto- 
sis in ANur77 Tg Mice.  There  was  no  significant  abnor- 
mality in  the  development of thymocytes in  ANur77  Tg 
mice (Fig.  2 A  and Table 1).  To characterize the function 
of the ANur77  transgene, we examined whether apoptosis 
induced  by  CD3/TCR  signaling  was  impaired  in  thy- 
mocytes of ANur77  Tg mice.  Non-Tg and  ANur77  Tg 
mice were treated in vivo with control, anti-CD3, or anti- 
TCR. antibodies. Anti-CD3 antibody treatment led to de- 
pletion of 86% of the total and 99% of the DP thymocytes 
in non-Tg mice (Table  1)  and reduced  the percentage of 
DP  thymocytes to 4%  (Fig.  2  A).  In contrast,  anti-CD3- 
induced deletion of thymocytes was less eflacient in ANur77 
Tg mice, with depletion of 50% of the total and 63% of the 
DP  thymocytes (Table  1)  and  reduced  the  percentage  of 
DP thymocytes to 31% (Fig.  2 A). Depletion ofCD4 + and 
CD8 +  thymocytes was also inhibited  after CD3  antibody 
treatment of ANur77 Tg mice, whereas deletion of double 
negative (DN) thymocytes was equivalent in both non-Tg 
and  ANur77  Tg  mice  (Table  1).  Although  anti-CD3- 
induced  apoptosis was inhibited  in ANur77  Tg mice, not 
all  pathways of thymocyte apoptosis were  inhibited  since 
there  was  no  significant  difference  in  dexamethasone- 
induced thymocyte deletion comparing non-Tg and ANur77 
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Figure 3.  Thymocyte  apoptosis induced by anti-CD3 
and  dexamethasone in  vitro. The  thymocytes were 
prepared from non-Tg and ANur77 Tg mice. 2 ￿  106/ 
ml thymocytes  were cultured with plate-bound anti- 
CD3 or control hamster IgG (10 /a.g/ml) or 10 I.rM 
dexamethasone for the indicated time. Apoptosis was 
determined by TUNEL staining. (O) Non-Tg and (0) 
ANur77 Tg mice. 
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Tg mice  (Fig.  2  A).  Cell sorting and terminal digoxigenin 
nucleotide  endlabeling  (TUNEL)  staining  verified  that 
anti-CD3 treatment in vivo resulted in extensive apoptosis 
of  thymocytes  (Fig,  2  B).  To  determine  whether  the 
ANur77 transgene interfered with early signaling events af- 
ter  CD3/TCR  stimulation,  tyrosine  phosphorylation  of 
the CD3~ chain was examined in the peripheral T  cells af- 
ter anti-CD3 cross-linking. There was no significant differ- 
ence between the extent oftyrosine phosphorylation of the 
CD3~ chain in the T  cells of both non-Tg and ANur77 Tg 
mice (Fig. 2  C). 
To determine if the inhibition ofanti-CD3-induced  de- 
pletion of thymocytes  by the  ANur77  transgene was  spe- 
cific for CD3/TCR  signaling, or is a nonspecific effect re- 
lated  to  an  in  vivo  stress  response  induced  by  anti-CD3 
treatment, thymocytes obtained from non-Tg and ANur77 
Figure 4.  Effect of ANur77 transgene  on thymocyte  subpopulations. 
D~/HY TCR single Tg female and male mice or ANur77-Db/HY dou- 
ble Tg female and male mice were analyzed for expression of CD4 and 
CD8. The numbers of thymocytes in each subpopulation were derived by 
multiplying the percent  thymocytes  in each subpopulation  by the  total 
number of thymocytes. These are representative of typical results for at 
least three mice analyzed individually. 
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Figure 5.  Decreased deletion of M33*CD4+CD8+  thymocytes in ANur77-Db/HY TCR double Tg male mice. Db/HY TCR single Tg female or 
male mice or ANur77-Db/Hy double Tg female or male mice were analyzed for expression of CD4, CD8, and the anti-TCR transgene mAb M33. Per- 
cent thymocytes expressing  high levels of M33 is shown by the cursor. These are representative of typical results for at least three mice analyzed individually. 
1884  Nur77/Nurr1 Response Element Signals T Cell Apoptosis Tg mice were cultured in vitro for different lengths of time 
with  either  anti-CD3  or  dexamethasone  (Fig.  3).  There 
was no difference in the numbers of thymocytes undergo- 
ing  dexamethasone-induced  apoptosis,  whereas  the  thy- 
mocytes from ANur77 Tg mice exhibited decreased apop- 
tosis  when  cultured  with  anti-CD3  (Fig.  3).  This  result 
strengthens the in vivo data indicating that the inhibition of 
apoptosis of CD4+CD8 + thymocytes in ANur77  Tg mice 
was specific for apoptosis induced by CD3/TCR  signaling. 
Decreased  Deletion  of CD4 + 8 + Thymocytes  in ANur77-EP / 
HY  TCR  Double Tg Male Mice.  The Db/Hy TCP, Tg male 
mouse has been extensively analyzed as a model for analysis 
of positive  and  negative  selection.  The  Db/HY-reactive 
thymocytes exhibit extensive positive selection in Db/Hy 
TCR Tg female mice and are extensively deleted at the DP 
stage of thymocyte development in D~/HY TC1L Tg male 
mice  (60-63).  To  determine  whether  interruption  of 
Nur77/Nurrl  function in ANur77 Tg mice leads to defec- 
tive  positive  and  negative  selection  of thymocytes,  H-2  b 
ANur77  Tg mice were backcrossed to Db/HY  TCR  Tg 
C57BL/6  mice.  In ANur77-Db/HY TCP, double Tg fe- 
male mice, there were equal numbers of total and DN thy- 
mocytes  compared  with  Db/Hy  TCR  Tg  female  mice. 
The ANur77  transgene resulted in a significant decrease in 
the  number of DP  and  CD8 +  thymocytes expressing the 
Db/HY-reactive Tg TCR (detected by the mAb M33) and 
a  significant  increase  in  the  number  of CD4  thymocytes 
expressing  an  endogenously  rearranged  TCR  (Figs.  4  A 
and 5). Flow cytometric analysis indicated that in ANur77- 
Db/Hy TCP,. double Tg female mice, only 18% of DP and 
48% of CD8 thymocytes expressed the Tg TCIL compared 
with 32 and 94% in Db/Hy TCK Tg female mice in the 
absence of the ANur77  transgene  (Fig.  5).  This result sug- 
gested that the ANur77  transgene may have an inhibitory 
effect on positive selection of thymocytes in female TC1L 
Tg mice. 
Db/Hy TCIL Tg male mice exhibited a 10-fold decrease 
in total thymocyte number and nearly complete deletion of 
DP and CD8  bright thymocytes due to negative selection of 
thymocytes bearing  the  Tg  TCR.  Several  changes  were 
observed in the thymus of the C57BL/6 ANur77-Db/Hy 
TCR double Tg male mice compared with that of Db/Hy 
TCIL Tg male mice. First,  there was a fourfold increase in 
total thymocytes that comprised a 20-fold increase in CD4  ~~ 
CD8  ~~  DP thymocytes and a fivefold increase in CD8 thy- 
mocytes (Fig.  4  B).  Second, increased numbers of DP and 
CD8 thymocytes in ANur77-Db/Hy TCR Tg male mice 
expressed the  Tg TCP,..  70% of CD4+CD8 +  thymocytes 
were  also  M33  positive in  the  ANur77-Tg71  double  Tg 
male compared with  17% in D~/HY TCR  Tg male mice 
(Fig.  5).  Third,  in ANur77-Db/Hy TCR  Tg male mice, 
there was the appearance of a substantial number of CD8 
thymocytes  that  exhibited  high  levels  of  expression  of 
CD8; 70-80% of these thymocytes expressed the Tg TCR 
(Fig.  5).  This population was absent in  the  DU/HY male 
mice.  Taken together,  these  results indicate  that  negative 
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Figure 6.  Increased  M33+CD8  + LN T cells in the ANur77-Db/HY TCR double Tg male mice. Single celt suspensions  from LN were prepared  from 
Db/HY TCk single Tg female  and male mice or ANur77=Db/HY TCR double Tg male mice. Cells were labeled with anti-CD4, anti-CD8, and M33 
recognizing the Db/Hy Tg TCR.. Flow cytometry  analysis  was carried out on 10,000 viable cells. Percentage cells in each subpopulation marked  by the 
gated cursors is indicated. These results are representative of three mice analyzed  individually. 
1885  Zhou et al, Table 2.  Phenotype  of LN T Cell in ANurr77-Db/HY Tg Mice 
M33 +  M33 + 
Mouse  Sex  n  Total  CD8 +  CD8- 
Non-Tg  M  5  1.9 -+ 0.5*  <0.001  <0.001 
ANur77 Tg  M  5  2.0 +  0.4  <0.001  <0.001 
Du/HY  M  5  0.5  +  0.1  0.09  _  0.01  0.25  +  0.03 
ANur77-DU/HY  M  5  1.4 +  0.3  0.68  +  0.07  0.06 __- 0.01 
Non-Tg  F  5  1.8 +  0.5  <0.00l  <0.001 
ANur77 Tg  F  5  1.9 +  0.6  <0.001  <0.001 
Du/HY  F  5  1.5 +  0.3  0.2 -+ 0.05  0.08 -+ 0.02 
ANur77-Db/Hy  F  5  1.7 -+ 0.4  0.08 •  0.02  0.06 +  0.01 
* Total of two axiUary and two inguinal LN per mouse. All mice were 8- 
10 wk of age. Total represents the mean +  SEM of five mice per group 
assayed separately. 
*Number ofLN T cells expressing either the Db/Hy TCR-~x/[3 recog- 
nized by the anticlonotypic mAb, M33, or CD8. The number was derived 
by multiplying the percent gated cells after flow cytometry by the total 
number of LN cells. The number represents the mean +  SEM ofT cells 
with  the indicated surface marker of five mice per group assayed sepa- 
rately. 
selection  of the  autospecific  Db/HY-reactive  thymocytes 
was  inhibited  in  ANur77-Db/HY  TCR  compared  with 
Db/Hy TCR  Tg male mice. 
Increased M33+ CD8 + LN T  Cells in the ANur77-Db/HY 
TCR Double  Tg Male Mice.  To determine whether defec- 
tive  thymic clonal deletion leads to the escape of autospe- 
cific T  cells  to the periphery,  the phenotype of LN T  cells 
was analyzed.  In Db/Hy  female mice,  most of the  CD4 § 
LN  T  ceils  in  the  Db/Hy  TCR  Tg  female  mice  were 
M33-  indicating  expression  of endogenously  rearranged 
TCR  genes (Fig. 6). Approximately 10% of LN cells  were 
M33 §  and  CD8 §  This phenotype was greatly reduced in 
ANur77-Db/Hy TCR  Tg female mice in which only 1% 
of LN cells were CD8 § and M33 +, whereas most CD8 + T 
cells  expressed an endogenously rearranged TCR transgene 
(Fig.  6).  In the  Db/Hy  male mice,  47%  of LN cells were 
CD4-CD8-  but  expressed  equivalent  levels  of the  M33 
TCR  transgene as observed in female mice.  In these mice, 
peripheral  LN  cells  expressed  downmodulated  levels  of 
CD8 and also expressed  the Db/Hy  TCR  transgene  (Fig. 
6).  In  the  ANur77-Db/Hy  TCR  double  Tg  male  mice, 
there was a significant increase in the total number of cells, 
and  M33+CD8 +  LN  T  cells,  but  a  decreased  number  of 
M33+CD4-CD8 -  T  cells  (Table  2).  Compared with Db/ 
HY Tg male mice, most M33 + T  cells  expressed interme- 
diate to high levels of CD8 (Fig. 6). 
Tolerance of LN T  cells in ANur77-Db/HY TCR  Tg Male 
Mice.  To  determine  if the  increased  numbers  of CD8 + 
M33 +  LN T  cells  in  the  double  Tg male  mice  exhibited 
loss of tolerance, proliferation was analyzed using irradiated 
D b male  stimulator  cells  (Fig.  7  A).  The  proliferative  re- 
sponse was greatly reduced in both Db/Hy  and ANur77- 
Db/HY male compared with female Tg mice (Fig. 7).  Spe- 
cific lysis was assayed using chromium-labeled D b male tar- 
get  cells  (Fig.  7  B).  There  was low specific lysis  of target 
cells  by LN T  cells  from both  Db/Hy  and  ANur77-Db/ 
HY TCR  male  Tg mice compared with  female  Tg mice 
(Fig.  7  B).  The  proliferative  and  cytotoxic  response  was 
specific to Db/HY antigen  as  there  was  no increased spe- 
cific proliferation or lysis when D b female cells were used as 
stimulators or targets (Fig. 7,  C and D). 
Increased In  Vivo  Activation  and  Apoptosis  in  the  LN  of 
ANur77-Db/HYMice.  In spite of inefficient thymic clonal 
deletion  in  ANur77-Db/Hy  Tg male  mice,  peripheral  T 
cell tolerance was maintained,  suggesting there are alterna- 
tive mechanisms to maintain T  cell tolerance.  Fas- and Fas 
ligand-mediated apoptosis has been shown to play a critical 
role in activation-induced cell death  (AICD) of peripheral 
T  cells  (64--67).  To  determine  whether A1CD in the  pe- 
riphery compensated for defective  thymic clonal deletion, 
in vivo activation and apoptosis were examined in the LN 
by BrdU labeling of cycling ceils  and TUNEL staining,  re- 
spectively (Fig.  8 A). There was increased uptake of BrdU 
by  LN  T  cells  in  the  ANur77-Db/Hy  TCP,,  compared 
with  the  Db/HY  TCR  Tg male  mice and  DU/HY  TCR 
Tg  female  mice  with  or  without  the  ANur77  transgene 
(Fig.  8  A).  This  increased  activation  was  specific  for  the 
Db/Hy antigen as no increased BrdU uptake was observed 
in ANur77-Db/HY TCR  double Tg female mice.  In vivo 
apoptosis was also analyzed by in situ  TUNEL staining of 
LN. There was significantly increased apoptosis in the LN 
of ANur77-Db/Hy  TCR  male mice compared with  Db/ 
HY TCK single Tg male mice and ANur77-Db/Hy TC1K 
double  Tg female  mice  (Fig.  8  A).  These  results  indicate 
that there was increased in vivo activation and apoptosis in 
the LN of dlNur77-Db/Hy TC1K Tg male mice and sug- 
gest that tolerance might be maintained by increased AICD 
in the periphery ofANur77-Db/Hy TCR double Tg male 
mice. 
Fas  and  Fas ligand  expression  by LN  T  cells  from Db/ 
HY  TCR  single  and  ANur77-Db/Hy  TC1K  double  Tg 
male mice was determined (Fig. 8 B). Previous studies have 
shown  that  two  major T  cell populations  express  the  Tg 
Db/Hy TC1K in D b male mice: one is CD4-CD8-  and the 
other is  CD8 aun. Both  T  cell populations  are  functionally 
anergic. Fas was expressed at low level in both T  cell popu- 
lations  of Db/Hy  male  mice.  In  contrast,  Fas  expression 
was increased on the self-reactive M33 + CD8 + T  ceils  but 
not on the M33+CD8 -  T  cells of ANur77-Db/HY TC1L 
double  Tg  male  mice.  Fas  ligand  expression  was  deter- 
mined  by  culture  of different  effector/target  ratios  of T 
cells from the LN of different mice with a 51Cr-labeled Fas- 
sensitive cell line (Fig. 8 B).  There was increased Fas ligand 
production  by  T  cells  from  the  ANur77-Db/Hy  TC1K 
double Tg male mice compared with the Db/Hy TC1K Tg 
male  mice  that  could  be  inhibited  by  a  soluble  FasFP. 
These  results  indicate  that  in  dINur77-Db/Hy  TCIK  Tg 
male mice, peripheral tolerance was likely maintained by a 
Fas-mediated AICD mechanism. 
] 886  Nur77/Nurrl Response Element Signals T Cell Apoptosis Discussion 
Nut77 mutant mice were recently found to not exhibit 
defective apoptosis after anti-CD3-induced death and did 
not exhibit defective thymocyte development or apoptosis 
after crossing with the Db/HY TCK Tg mice (51). Kesults 
of previous  investigators  and  the  present  results  indicate 
that inhibition of the DNA binding by overexpression of 
the NBtLE-binding portion of Nut77  results in defective 
apoptosis (48, 49). Nuclear factors capable of  binding to the 
NBKE consist of several members of a supeffamily sharing 
homology of the DNA-binding domain. The NBRE con- 
sensus  sequence is AAAGGTCA and is composed of two 
5' adenine nucleotides and the half-site of the estrogen re- 
sponse element (41-47). The second member of this family 
has been recently isolated from a human lymphoid cell line 
PEEK  after induction  of apoptosis  and  is  referred to  as 
TINUK in human and Nurrl in mouse (50). TINUK has 
a highly homologous DNA-binding domain to Nut77,  as 
do other members of this family described in other species, 
but there was little homology in the NH2-terminal effector 
function region.  TCK-mediated signaling results in early 
induction of Nut77 which peaks after 1 h, and later induc- 
tion of TINUR which peaks at 24 h  in PEEK cells  (50). 
Expression of TINUK also correlated with apoptosis which 
was also maximal 24 h  after anti-TCK signaling. The dif- 
ference in the  kinetics of peak expression of Nut77  and 
TINUK expression leads to the conclusion that different 
genes may play complementary roles in T  cell activation or 
apoptosis.  The  preferential  inhibition  of  apoptosis  of 
CD4+8 +  thymocyte by blocking  the  NBKE,  combined 
with previous results that Nut77 knockout does not inhibit 
apoptosis of CD4+8 + thymocytes, support the conclusion 
that  other factors that  interact with  the  NBKE,  such  as 
Nurrl/TINUK, play a role in apoptosis of thymocytes. 
Although Nurrl and Nur77 have been shown to be im- 
portant in TCK-mediated apoptosis in T  cell hybridomas 
in vitro, the importance of Nut77 and Nurrl  in negative 
selection and clonal deletion in the thymus has not been es- 
tablished.  The  present  results  indicate  that  apoptosis  of 
CD4 + CD8 + (DP) thymocytes after TCK/CD3 signaling 
is inhibited in the ANur77 Tg mice and suggest that this 
event is dependent on DNA-binding factors, including Nurrl 
and Nut77.  This is consistent with results of previous in- 
vestigators  who  have  demonstrated  that  apoptosis  after 
anti-TCR or anti-CD3 is highly dependent on a functional 
NGFI-B/Nur77 pathway (48, 49). Negative selection was 
also analyzed in the Db/Hy TCK Tg male mice. The pres- 
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Fig,  ure 7.  Proliferation  and cytotoxicity  of 
LN T ceils. LN T cells from the indicated 
single or double Tg mice were purified  by 
negative selection  after  passing over a T cell 
column. Proliferation  was assayed afier  cul- 
ture of purified LN T cells with irradiated 
D  b male (A) or D  b female (C) stimulator 
cells for the indicated time. Equal numbers 
ofT ceils  were used at different  effector/tar- 
get ratios to lyse  STCr-hbeled  D  b  male (B) or 
D  b female (D) target cells. Percent specific 
lysis or proliferation  is indicated as the mean 
+-- SEM for at least three individual mice 
analyzed in triplicate. 
1887  Zhou et al. ence of the ANur77 transgene resulted in increased num- 
bers  of CD4+CD8 +  thymocytes and  the  appearance  of 
more  mature  CD8 §  thymocytes both  expressing the  au- 
tospecific Db/HY Tg TCR.  The increase in the produc- 
tion  of CD4+8 +  (DP)  thymocytes in Db/Hy male mice 
was not due to increased positive selection for these cells. 
This is supported by a decrease in CD4+8 + thymocytes in 
the ANur77-Db/Hy TCtL Tg female mice. The appear- 
ance  of  mature  CD8  single  positive  autospecific  thy- 
mocytes suggests a deletion defect at a mature stage of thy- 
mocyte development. Together, these data strongly suggest 
that the family of  DNA-binding proteins, including Nurrl 
and Nut77 is directly involved in signaling of positive and 
negative selection during T cell development in the thymus. 
After anti-TCR or anti-CD3 cross-linking in vivo, apo- 
ptosis ofCD4+8  + thymocytes was inhibited in the ANur77 
Tg mice.  Failure  to  completely block apoptosis in  these 
mice could be due either to the presence of other apoptosis 
pathways that do not involve the NBRE  or to a  "leaky" 
blockade of the NBtLE caused by a lack of complete com- 
petition of DNA-binding sites  by the  truncated, inactive 
ANur77 protein. We favor the first possibility because in 
vitro, anti-CD3 apoptosis was not significantly greater than 
control antibody-induced apoptosis (Fig. 3), providing evi- 
dence that in ANur77 Tg mice, anti-CD3-induced apop- 
tosis via the NBRE is functionally  inactivated. Other apop- 
tosis  pathways  exist  in  the  thymus  in  vivo  and  these 
pathways may operate at different developmental stages of 
thymocytes or in association with different signaling events 
in addition to anti-CD3.  Increased T  cell survival  during 
negative  selection  has  been  observed  in  bcl-2/Db/Hy 
TCP,.-a//3 double Tg mice (34-36).  Increased survival of 
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Figure  8.  Increased activation and 
apoptosis of LN cells in Db/HY TCK 
and ANur77-Db/Hy TCK Tg mice. 
(A) Immunohistochemical  analysis  for 
BrdU  incorporation and  apoptosis. 
Mice were injected with 1 mg BrdU 
every 6 h for 24 h. LN sectiom were 
analyzed for DNA  incorporation of 
BrdU using the anti-BrdU antibody  or 
for apoptosis using the TUNEL tech- 
nique. The figure is representative of 
at least eight LN from three different 
mice. (B) Fas expression and Fas ligand 
activity. Single ceil suspensiom were 
prepared from LN of IY~  TCK 
Tg male and ANur77-Db/Hy TCK 
double Tg male mice. Cells were la- 
beled with antibodies against anti-Fas, 
anti-CDS,  and  M33, followed by 
analysis of 10,000 cells by flow cytom- 
etry.  Cells  were  gated  into 
M33+CD8  + and M33+CD8  - popula- 
tions, and Fas expression on each pop- 
ulation  is  shown. These results are 
representative of three mice analyzed 
individually. Fas ligand activity  by un- 
stimulated LN cells was determined by 
the extent oflysis of SlCr-hbeled Fas  + 
target cells using different effector/tar- 
get  ratios.  Specificity for  Fas-Fas 
ligand interaction was determined by 
the inhibitory effect in the presence of 
FasFP. Percent specific lysis is indi- 
cated as the mean +_ SEM for at least 
three individual mice analyzed  in trip- 
licate. 
umelected thymocytes and inhibition of negative selection 
of thymocytes was observed in bd-2/Db/Hy  TCIL female 
and male mice (34).  Another possibility is that the NB1LE 
might  be  one  factor leading  to  regulation  of apoptosis- 
related proteins such as Bcl-Xs and Bax which promote ap- 
optosis;  or downregulation  of proteins  such  as Bcl-2  and 
BcI-X  t, which inhibit apoptosis (68-71). 
Another important pathway of apoptosis for thymocytes 
is dexamethasone-induced apoptosis (72, 73). The lack of  in- 
hibition of dexamethasone-induced apoptosis in the ANur77 
Tg mice is significant since  this indicates that there  is no 
competitive inhibition between the Nur77/Nurrl  orphan 
steroid receptors either at the level of cytoplasmic steroid 
binding or at the receptor-DNA binding site with gluco- 
corticoids. This lack of inhibition between dexamethasone 
apoptosis and Nur77/Nurrl  apoptosis indicates that apop- 
tosis is mediated by separate independent pathways. Taken 
together, there are multiple independent pathways of thy- 
mocyte apoptosis related to TCK/CD3  signaling that may 
be affected by inhibition of Nurrl/Nur77  interaction with 
NBILE. 
Functional  blockade of the  NBR.E  did not  greatly in- 
hibit  the  T  cell  activation signal  after TCK/CD3  cross- 
linking.  There was normal phosphorylation of the  CD3~ 
chain in ANur77 Tg mice. Also, proliferation after TCR./ 
CD3-mediated activation of LN T  cells was increased in 
the  ANur77-Db/Hy  TCK  Tg male  mice  and  was  only 
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slightly decreased in T  cells from ANur77  Db/Hy  TCR 
Tg female mice compared with  Db/Hy  single  TCIL Tg 
male and female mice, after culture with D b male stimula- 
tor  cells  (Fig.  7).  Proliferation  after stimulation  was very 
low in the Db/Hy male mice, and this was increased ap- 
proximately  10-fold  in  the  ANur77-Db/Hy  double  Tg 
male mice. Increased proliferation could not be accounted 
for by an increase in the number of M33 + CD8 + T  cells, 
which were increased only twofold.  These results suggest 
that alternative pathways to signal proliferation after stimu- 
lation through the TCK/CD3 molecules are present in ad- 
dition to the ANur77  pathway, and these result in nearly 
normal  proliferation  after  TCK/CD8  signaling  in  the 
ANur77 Tg mice. 
In  ANur77  Tg  male  mice,  there  was  an  increase  in 
M33 + CD8 + T  cells in the LN which resulted from inefii- 
cient thymic clonal deletion and compensatory increase in 
LN peripheral expansion followed by clonal deletion. Acti- 
vation-induced  apoptosis  of nontolerant  T  cells  is  sup- 
ported by the observation of a specific increase m BrdU in- 
corporation in vivo in Nur77-Db/Hy TCK Tg male mice 
but not in ANur77-Db/HY TCK Tg female mice lacking 
the HY antigen. Also, increased T  cell activation was asso- 
ciated with increased apoptosis in  ANur77-Db/Hy TC1L 
Tg male but not ANur77-Db/Hy TCK Tg female mice. 
Fas-Fas ligand interaction has been shown to be an impor- 
tant  mechanism for  activation-induced  apoptosis  (64--67, 74, 75). Several lines of evidence indicate that this AICD in 
ANur77-Db/Hy TCR  Tg male mice was due  to Fas-Fas 
ligand interaction. First, apoptosis in vitro could be blocked 
by the  FasFP.  Second,  Fas  expression was increased in the 
M33 +, CD8 + T  cells,  but not in the M33 §  CD8- T  cells, 
ofNur77-Db/Hy  TCtL Tg male mice, consistent with on- 
going AICD using a Fas-Fas ligand pathway. Finally, there 
was  increased  Fas  ligand  production  by LN T  cells  from 
Nur77-Db/Hy TCR  Tg male but not female mice. 
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